Legend Biotech $403 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Revolution Medicines $264.5 million follow-on offering
The shares are listed on Nasdaq
Akeso HK$582 million share placement
We advised Akeso in the placement of new shares
Gracell Biotechnologies at-the-market offering
The ADSs are listed on the Nasdaq Global Select Market
Applied Therapeutics $30 million stock and warrants offering
The stock is listed on the Nasdaq Global Market
Laekna Therapeutics $61 million Series D financing
We are advising Laekna Therapeutics in connection with its Series D financing
Bausch + Lomb $630 million IPO
We are advising Bausch Health on the separation of its eye health business into a new public company, Bausch + Lomb
Anthem $1.3 billion senior notes offering
The investment-grade notes are due 2032 and 2052
Deciphera Pharmaceuticals $172.5 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
HilleVax $200 million IPO
The shares are listed on the Nasdaq Global Select Market